title: Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene.
authors.forename: Eswar
authors.initials: E
authors.lastname: Tipirneni
authors.forename: Amanpreet
authors.initials: A
authors.lastname: Buttar
authors.forename: Doreen
authors.initials: D
authors.lastname: Brettler
authors.forename: Patricia
authors.initials: P
authors.lastname: Miron
authors.forename: Venu
authors.initials: V
authors.lastname: Bathini
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy / Q000235:genetics*; D010879:Piperazines / Q000627:therapeutic use; D050783:Proto-Oncogene Proteins c-ets / Q000235:genetics* / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics* / Q000378:metabolism; D012097:Repressor Proteins / Q000235:genetics* / Q000378:metabolism; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D000068877:Imatinib Mesylate; D010879:Piperazines; D050783:Proto-Oncogene Proteins c-ets; D011743:Pyrimidines; D020797:Receptor, Platelet-Derived Growth Factor beta; D011993:Recombinant Fusion Proteins; D012097:Repressor Proteins; D000097764:ETS Translocation Variant 6 Protein